James F. Blake

Biochemistry, Genetics and Molecular BiologyComputer SciencePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Chppter 30. Recent advances in virtual ligand screening”.

Chppter 30. Recent advances in virtual ligand screening

Annual Reports in Medicinal Chemistry(2003)10.1016/s0065-7743(03)38031-5

N/A

1.2DataRank · unranked

11 citations

Ellen R. Laird, James F. Blake

Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS G12D Inhibitor

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c01688

N/A

0DataRank · unranked

716 citations

Shelley Allen, James F. Blake, Vickie Bowcut, David M. Briere, Andrew Calinisan +23 more